Taken together, genetic targeting of Dnmt1 in ECs strikingly inhibits tumor growth despite subtle changes in vessel morphology and moderate reductions in vessel branch length; we therefore considered secondary mechanisms whereby loss of Dnmt1 in ECs could impair tumor progression. Here, DNMT1 is linked to neoplasm.